Matthew Malone, DO
Geriatric Psychiatry · Oro Valley, AZNPI 1912952136
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,101 of the $1,661 with a category attached, or 66.3%. E.r. Squibb & Sons, L.L.C. accounts for 84.8% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $1,552, more than ten times the $16 reported in 2019.
Across 7 payments — averaging $237.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1K
- Roche Molecular Systems, Inc.$143
- Acadia Pharmaceuticals Inc$64
- Johnson & Johnson$29
- AbbVie$16
Across 7 payments — averaging $59,818 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$416K
- Eli Lilly$3K
What the payments were for
- Travel & lodging$1,10166%
- Food & beverage$56034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 3 | $1,409 |
| Roche Molecular Systems, Inc. | 1 | $143 |
| Acadia Pharmaceuticals Inc | 1 | $64 |
| Johnson & Johnson | 1 | $29 |
| AbbVie | 1 | $16 |
How this compares
Too few geriatric psychiatry providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Thiothixene | 11 | $2,460 |
| Memantine Hcl ErMemantine Hcl | 17 | $2,047 |
| Donepezil Hcl | 123 | $1,864 |
| Memantine Hcl | 42 | $1,447 |
| Mirtazapine | 29 | $1,047 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 37 | $852 |
| Bupropion XlBupropion Hcl | 26 | $819 |
| Duloxetine Hcl | 17 | $768 |
| Quetiapine Fumarate | 23 | $723 |
| Sertraline Hcl | 29 | $304 |
| Escitalopram Oxalate | 22 | $256 |
| Fluoxetine Hcl | 18 | $245 |
| Lamotrigine | 23 | $237 |
| Trazodone Hcl | 33 | $220 |
| Alprazolam | 19 | $209 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Oro Valley
- Daniel CohenTucson$622
- Justyna Perucka-PalominoTucson$120
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.